Issue 12, 2017

Prediction of drug–pathway interaction pairs with a disease-combined LSA-PU-KNN method

Abstract

Prediction of new associations between drugs and targeting pathways can provide valuable clues for drug discovery & development. However, information integration and a class-imbalance problem are important challenges for available prediction methods. This paper proposes a prediction of potential associations between drugs and pathways based on a disease-related LSA-PU-KNN method. Firstly, we built a drug–disease–pathway network and combined the drug–disease and pathway–disease features obtained by different types of feature profiles. Then we applied a latent semantic analysis (LSA) method to perform dimension reduction by combining positive-unlabeled (PU) learning and k nearest neighbors (KNN) method. The experimental results showed that our method can achieve a higher AUC (the area under the ROC curve) and AUPR (the area under the PR curve) than other typical methods. Furthermore, some interesting drug–pathway interaction pairs were identified and validated.

Graphical abstract: Prediction of drug–pathway interaction pairs with a disease-combined LSA-PU-KNN method

Article information

Article type
Paper
Submitted
20 Jul 2017
Accepted
27 Sep 2017
First published
12 Oct 2017

Mol. BioSyst., 2017,13, 2583-2591

Prediction of drug–pathway interaction pairs with a disease-combined LSA-PU-KNN method

F. Chen, H. Jiang and Z. Jiang, Mol. BioSyst., 2017, 13, 2583 DOI: 10.1039/C7MB00441A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements